Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac …
A Arshad, AJ Moss, E Foster, L Padeletti… - Journal of the American …, 2011 - jacc.org
A Arshad, AJ Moss, E Foster, L Padeletti, A Barsheshet, I Goldenberg, H Greenberg, WJ Hall…
Journal of the American College of Cardiology, 2011•jacc.orgObjectives: The purpose of this study was to investigate the factors related to sex-specific
outcomes for death and heart failure events in the MADIT-CRT (Multicenter Automatic
Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) trial. Background:
In the MADIT-CRT trial, women seemed to achieve a better result from resynchronization
therapy than men. Methods: All 1,820 patients (453 female and 1,367 male) enrolled in the
MADIT-CRT trial were included in this sex-specific outcome analysis that compared the …
outcomes for death and heart failure events in the MADIT-CRT (Multicenter Automatic
Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) trial. Background:
In the MADIT-CRT trial, women seemed to achieve a better result from resynchronization
therapy than men. Methods: All 1,820 patients (453 female and 1,367 male) enrolled in the
MADIT-CRT trial were included in this sex-specific outcome analysis that compared the …
Objectives
The purpose of this study was to investigate the factors related to sex-specific outcomes for death and heart failure events in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) trial.
Background
In the MADIT-CRT trial, women seemed to achieve a better result from resynchronization therapy than men.
Methods
All 1,820 patients (453 female and 1,367 male) enrolled in the MADIT-CRT trial were included in this sex-specific outcome analysis that compared the effect of cardiac resynchronization therapy with defibrillator (CRT-D) relative to implanted cardioverter-defibrillator (ICD) on death or heart failure (whichever came first), heart failure only, and death at any time.
Results
Female patients were more likely to have nonischemic cardiomyopathy and left bundle branch block and less likely to have renal dysfunction than male patients. Overall, female patients had a better result from CRT-D therapy than male patients, with a significant 69% reduction in death or heart failure (hazard ratio: 0.31, p < 0.001) and 70% reduction in heart failure alone (hazard ratio: 0.30, p < 0.001). Women had a significant 72% reduction in all-cause mortality in the total population (hazard ratio: 0.28, p = 0.02) and significant 82% and 78% reductions in mortality in those with QRS ≥150 ms and with left bundle branch block conduction disturbance, respectively, with sex-by-treatment interactions for mortality reduction significant at p < 0.05 in each of these 3 patient groups. These beneficial CRT-D effects among women were associated with consistently greater echocardiographic evidence of reverse cardiac remodeling in women than in men.
Conclusions
Women in the MADIT-CRT trial obtained significantly greater reductions in death or heart failure (whichever came first), heart failure alone, and all-cause mortality with CRT-D therapy than men, with consistently greater echocardiographic evidence of reverse cardiac remodeling in women than in men. (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]; NCT00180271).
jacc.org